Fund

FreeS Fund

峰瑞资本

FreeS Fund (峰瑞资本) is a Chinese venture capital firm co-founded by Li Feng, who serves as founding partner . Established in 2015, the firm has grown from an early-stage focused fund into a manager that also actively deploys growth capital . Its investment thesis centers on finding "non-consensus but imaginative" opportunities, particularly at the intersection of disciplines—what it calls "cross-disciplinary" breakthroughs where science converges .

The firm's three core sectors are consumer/TMT, deep tech, and biotech . Its portfolio includes several public companies—Three Squirrels (SZSE), 360 DigiTech (NASDAQ), Uber Global (NYSE), and Unity (NYSE)—alongside a deep roster of venture-backed names such as XtalPi, Bluepha, METiS Pharmaceuticals, SATURNBIRD, and PatPat . FreeS Fund has been especially active in biotech, leading METiS Pharmaceuticals' angel round in late 2019 and following on through four subsequent rounds , and making an early bet on XtalPi back in 2016 .

The team includes founding partner Li Feng ("Uncle Feng"), executive director Liu Pengqi, and vice presidents Yan Qianhang and Shen Ying, among others . The firm also runs the FreeS Fellow program, a six-month initiative for students to source deals and produce research remotely .

AI-generated — may contain errors, please verify.

FreeS FundFund
峰瑞资本
渲染中…
Mentioned in 590 articles

Coverage